Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

First Results from CUORE: A Search for Lepton Number Violation via 0νββ Decay of ^{130}Te.

Alduino C, Alessandria F, Alfonso K, Andreotti E, Arnaboldi C, Avignone FT, Azzolini O, Balata M, Bandac I, Banks TI, Bari G, Barucci M, Beeman JW, Bellini F, Benato G, Bersani A, Biare D, Biassoni M, Bragazzi F, Branca A, Brofferio C, Bryant A, Buccheri A, Bucci C, Bulfon C, Camacho A, Caminata A, Canonica L, Cao XG, Capelli S, Capodiferro M, Cappelli L, Cardani L, Cariello M, Carniti P, Carrettoni M, Casali N, Cassina L, Cereseto R, Ceruti G, Chiarini A, Chiesa D, Chott N, Clemenza M, Conventi D, Copello S, Cosmelli C, Cremonesi O, Crescentini C, Creswick RJ, Cushman JS, D'Addabbo A, D'Aguanno D, Dafinei I, Datskov V, Davis CJ, Del Corso F, Dell'Oro S, Deninno MM, Di Domizio S, Di Vacri ML, Di Paolo L, Drobizhev A, Ejzak L, Faccini R, Fang DQ, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fujikawa BK, Gaigher R, Giachero A, Gironi L, Giuliani A, Gladstone L, Goett J, Gorla P, Gotti C, Guandalini C, Guerzoni M, Gutierrez TD, Haller EE, Han K, Hansen EV, Heeger KM, Hennings-Yeomans R, Hickerson KP, Huang HZ, Iannone M, Ioannucci L, Kadel R, Keppel G, Kogler L, Kolomensky YG, Leder A, Ligi C, Lim KE, Liu X, Ma YG, Maiano C, Maino M, Marini L, Martinez M, Martinez Amaya C, Maruyama RH, Mei Y, Moggi N, Morganti S, Mosteiro PJ, Nagorny SS, Napolitano T, Nastasi M, Nisi S, Nones C, Norman EB, Novati V, Nucciotti A, Nutini I, O'Donnell T, Olcese M, Olivieri E, Orio F, Orlandi D, Ouellet JL, Pagliarone CE, Pallavicini M, Palmieri V, Pattavina L, Pavan M, Pedretti M, Pedrotta R, Pelosi A, Pessina G, Pettinacci V, Piperno G, Pira C, Pirro S, Pozzi S, Previtali E, Reindl F, Rimondi F, Risegari L, Rosenfeld C, Rossi C, Rusconi C, Sakai M, Sala E, Salvioni C, Sangiorgio S, Santone D, Schaeffer D, Schmidt B, Schmidt J, Scielzo ND, Singh V, Sisti M, Smith AR, Stivanello F, Taffarello L, Tatananni L, Tenconi M, Terranova F, Tessaro M, Tomei C, Ventura G, Vignati M, Wagaarachchi SL, Wallig J, Wang BS, Wang HW, Welliver B, Wilson J, Wilson K, Winslow LA, Wise T, Zanotti L, Zarra C, Zhang GQ, Zhu BX, Zimmermann S, Zucchelli S; CUORE Collaboration.

Phys Rev Lett. 2018 Mar 30;120(13):132501. doi: 10.1103/PhysRevLett.120.132501.

2.

18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis.

Belloli S, Zanotti L, Murtaj V, Mazzon C, Di Grigoli G, Monterisi C, Masiello V, Iaccarino L, Cappelli A, Poliani PL, Politi LS, Moresco RM.

J Neuroinflammation. 2018 Feb 5;15(1):33. doi: 10.1186/s12974-017-1044-x.

3.

RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients.

Vezzoli M, Ravaggi A, Zanotti L, Miscioscia RA, Bignotti E, Ragnoli M, Gambino A, Ruggeri G, Calza S, Sartori E, Odicino F.

Sci Rep. 2017 Sep 5;7(1):10528. doi: 10.1038/s41598-017-11104-4.

4.

Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.

Zanotti L, Paderno A, Piazza C, Pagan E, Bignotti E, Romani C, Bandiera E, Calza S, Del Bon F, Nicolai P, Ravaggi A.

Laryngoscope. 2017 Nov;127(11):E408-E414. doi: 10.1002/lary.26797. Epub 2017 Aug 7.

PMID:
28782189
5.

Proteomic analysis of the secretome of human bone marrow-derived mesenchymal stem cells primed by pro-inflammatory cytokines.

Maffioli E, Nonnis S, Angioni R, Santagata F, Calì B, Zanotti L, Negri A, Viola A, Tedeschi G.

J Proteomics. 2017 Aug 23;166:115-126. doi: 10.1016/j.jprot.2017.07.012. Epub 2017 Jul 21.

PMID:
28739509
6.

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.

Zanotti L, Romani C, Tassone L, Todeschini P, Tassi RA, Bandiera E, Damia G, Ricci F, Ardighieri L, Calza S, Marchini S, Beltrame L, Tognon G, D'Incalci M, Pecorelli S, Sartori E, Odicino F, Ravaggi A, Bignotti E.

BMC Cancer. 2017 May 25;17(1):366. doi: 10.1186/s12885-017-3334-1.

7.

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma.

Bonetta A, Roviello G, Generali D, Zanotti L, Cappelletti MR, Pacifico C, Di Pierro F.

Res Rep Urol. 2017 Apr 26;9:65-69. doi: 10.2147/RRU.S133538. eCollection 2017.

8.

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.

Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A.

J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y.

9.

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

Roviello G, Zanotti L, Cappelletti MR, Gobbi A, Dester M, Paganini G, Pacifico C, Generali D, Roudi R.

Clin Exp Med. 2018 Feb;18(1):15-20. doi: 10.1007/s10238-017-0460-7. Epub 2017 Apr 8. Review.

PMID:
28391544
10.

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

Ravelli A, Roviello G, Cretella D, Cavazzoni A, Biondi A, Cappelletti MR, Zanotti L, Ferrero G, Ungari M, Zanconati F, Bottini A, Alfieri R, Petronini PG, Generali D.

Tumour Biol. 2017 Apr;39(4):1010428317695023. doi: 10.1177/1010428317695023. Review.

PMID:
28378631
11.

CDK4/6 inhibitors in HER2-positive breast cancer.

Corona SP, Ravelli A, Cretella D, Cappelletti MR, Zanotti L, Dester M, Gobbi A, Petronini PG, Generali D.

Crit Rev Oncol Hematol. 2017 Apr;112:208-214. doi: 10.1016/j.critrevonc.2017.02.022. Epub 2017 Feb 24. Review.

PMID:
28325261
12.

Superwellness Program: a cognitive-behavioral therapy-based group intervention to reduce weight gain in patients treated with antipsychotic drugs.

Magni LR, Ferrari C, Rossi G, Staffieri E, Uberti A, Lamonaca D, Boggian I, Merlin S, Primerano G, Mombrini A, Poli R, Saviotti FM, Caldera MT, Zanotti L, Rossi R.

Rev Bras Psiquiatr. 2017 Jul-Sep;39(3):244-251. doi: 10.1590/1516-4446-2016-1993. Epub 2017 Mar 13.

13.

Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.

Todeschini P, Salviato E, Paracchini L, Ferracin M, Petrillo M, Zanotti L, Tognon G, Gambino A, Calura E, Caratti G, Martini P, Beltrame L, Maragoni L, Gallo D, Odicino FE, Sartori E, Scambia G, Negrini M, Ravaggi A, D'Incalci M, Marchini S, Bignotti E, Romualdi C.

Cancer Lett. 2017 Mar 1;388:320-327. doi: 10.1016/j.canlet.2016.12.017. Epub 2016 Dec 22.

PMID:
28017893
14.

Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?

Roviello G, Zanotti L, Correale P, Gobbi A, Wigfield S, Guglielmi A, Pacifico C, Generali D.

Immunotherapy. 2017 Jan;9(1):25-32. doi: 10.2217/imt-2016-0107. Review.

PMID:
28000528
15.

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials.

Roviello G, Zanotti L, Cappelletti MR, Gobbi A, Borsella G, Pacifico C, Multari AG, Generali D.

Crit Rev Oncol Hematol. 2016 Dec;108:62-68. doi: 10.1016/j.critrevonc.2016.10.015. Epub 2016 Oct 29. Review.

PMID:
27931841
16.

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.

Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, Black J, Cocco E, Choi J, Zammataro L, Predolini F, Bonazzoli E, Bi M, Buza N, Hui P, Wong S, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Facchetti F, Falchetti M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Mane S, Angioli R, Terranova C, Quick CM, Edraki B, Bilgüvar K, Lee M, Choi M, Stiegler AL, Boggon TJ, Schlessinger J, Lifton RP, Santin AD.

Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12238-12243. Epub 2016 Oct 10.

17.

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials.

Roviello G, Cappelletti MR, Zanotti L, Gobbi A, Senti C, Bottini A, Ravelli A, Bonetta A, Paganini G, Generali D.

Medicine (Baltimore). 2016 Oct;95(43):e4636. Review.

18.

The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines.

Bandiera E, Todeschini P, Romani C, Zanotti L, Erba E, Colmegna B, Bignotti E, Santin AD, Sartori E, Odicino FE, Pecorelli S, Tassi RA, Ravaggi A.

Oncol Lett. 2016 Oct;12(4):2493-2500. Epub 2016 Aug 16.

19.

Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer.

Roviello G, Zanotti L, Gobbi A, Dester M, Generali D, Pacifico C, Cappelletti MR, Bonetta A.

Clin Genitourin Cancer. 2017 Jun;15(3):371-375. doi: 10.1016/j.clgc.2016.08.024. Epub 2016 Sep 8.

PMID:
27692697
20.

Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.

Bignotti E, Calza S, Tassi RA, Zanotti L, Bandiera E, Sartori E, Odicino FE, Ravaggi A, Todeschini P, Romani C.

J Cell Mol Med. 2016 Dec;20(12):2341-2348. doi: 10.1111/jcmm.12927. Epub 2016 Jul 15.

21.

Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis.

Roviello G, Zanotti L, Venturini S, Bottini A, Generali D.

Cancer Biol Ther. 2016 Sep;17(9):883-8. doi: 10.1080/15384047.2016.1210735. Epub 2016 Jul 14. Review.

22.

Apatinib for the treatment of gastric cancer.

Roviello G, Ravelli A, Fiaschi AI, Cappelletti MR, Gobbi A, Senti C, Zanotti L, Polom K, Reynolds AR, Fox SB, Generali D.

Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):887-92. doi: 10.1080/17474124.2016.1209407. Epub 2016 Jul 15. Review.

PMID:
27376400
23.

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

Roviello G, Zanotti L, Cappelletti MR, Gobbi A, Senti C, Bottini A, Generali D.

Clin Lung Cancer. 2016 Sep;17(5):334-340. doi: 10.1016/j.cllc.2016.05.008. Epub 2016 Jun 2. Review.

PMID:
27346522
24.

A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.

Roviello G, Milani M, Gobbi A, Dester M, Cappelletti MR, Allevi G, Aguggini S, Ravelli A, Gussago F, Cocconi A, Zanotti L, Senti C, Strina C, Bottini A, Generali D.

Future Oncol. 2016 Oct;12(19):2189-93. doi: 10.2217/fon-2016-0116. Epub 2016 Jun 21.

PMID:
27324108
25.

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials.

Roviello G, Sigala S, Sandhu S, Bonetta A, Cappelletti MR, Zanotti L, Bottini A, Sternberg CN, Fox SB, Generali D.

Eur J Cancer. 2016 Jul;61:111-21. doi: 10.1016/j.ejca.2016.04.002. Epub 2016 May 7. Review.

PMID:
27162152
26.

Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis.

Petrioli R, Roviello G, Zanotti L, Roviello F, Polom K, Bottini A, Marano L, Francini E, Marrelli D, Generali D.

Crit Rev Oncol Hematol. 2016 Jun;102:82-8. doi: 10.1016/j.critrevonc.2016.04.001. Epub 2016 Apr 8. Review.

PMID:
27083592
27.

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials.

Roviello G, Sigala S, Danesi R, Re MD, Bonetta A, Cappelletti MR, Zanotti L, Bottini A, Generali D.

Crit Rev Oncol Hematol. 2016 May;101:12-20. doi: 10.1016/j.critrevonc.2016.02.013. Epub 2016 Feb 27. Review.

PMID:
26971992
28.

Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.

Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM, Repaci A, Ribichini D, Gambineri A.

J Clin Endocrinol Metab. 2016 May;101(5):2013-22. doi: 10.1210/jc.2015-4009. Epub 2016 Mar 10.

PMID:
26964728
29.

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers.

Roviello G, Milani M, Gobbi A, Cappelletti MR, Zanotti L, Senti C, Bottini A, Strina C, Sigala S, Generali D.

Clin Breast Cancer. 2016 Jun;16(3):e57-9. doi: 10.1016/j.clbc.2016.02.012. Epub 2016 Feb 11.

PMID:
26943987
30.

Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1.

Zanotti L, Angioni R, Calì B, Soldani C, Ploia C, Moalli F, Gargesha M, D'Amico G, Elliman S, Tedeschi G, Maffioli E, Negri A, Zacchigna S, Sarukhan A, Stein JV, Viola A.

Leukemia. 2016 May;30(5):1143-54. doi: 10.1038/leu.2016.33. Epub 2016 Feb 22.

31.

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.

Romagnolo C, Leon AE, Fabricio ASC, Taborelli M, Polesel J, Del Pup L, Steffan A, Cervo S, Ravaggi A, Zanotti L, Bandiera E, Odicino FE, Scattolo N, Squarcina E, Papadakis C, Maggino T, Gion M.

Gynecol Oncol. 2016 May;141(2):303-311. doi: 10.1016/j.ygyno.2016.01.016. Epub 2016 Jan 19.

PMID:
26801941
32.

CCRL2 regulates M1/M2 polarization during EAE recovery phase.

Mazzon C, Zanotti L, Wang L, Del Prete A, Fontana E, Salvi V, Poliani PL, Sozzani S.

J Leukoc Biol. 2016 Jun;99(6):1027-33. doi: 10.1189/jlb.3MA0915-444RR. Epub 2016 Jan 7.

PMID:
26744451
33.

Effect of fetal bovine serum in culture media on MS analysis of mesenchymal stromal cells secretome.

Nonnis S, Maffioli E, Zanotti L, Santagata F, Negri A, Viola A, Elliman S, Tedeschi G.

EuPA Open Proteom. 2016 Jan 7;10:28-30. doi: 10.1016/j.euprot.2016.01.005. eCollection 2016 Mar.

34.

Mesenchymal stem cells: myths and reality.

Sarukhan A, Zanotti L, Viola A.

Swiss Med Wkly. 2015 Dec 23;145:w14229. doi: 10.4414/smw.2015.14229. eCollection 2015. Review.

35.

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery.

Romani C, Cocco E, Bignotti E, Moratto D, Bugatti A, Todeschini P, Bandiera E, Tassi R, Zanotti L, Pecorelli S, Sartori E, Odicino FE, de Marco A, Santin AD, Ravaggi A, Mitola S.

Oncotarget. 2015 Oct 27;6(33):34617-28. doi: 10.18632/oncotarget.5315.

36.

Search for Neutrinoless Double-Beta Decay of (130)Te with CUORE-0.

Alfonso K, Artusa DR, Avignone FT 3rd, Azzolini O, Balata M, Banks TI, Bari G, Beeman JW, Bellini F, Bersani A, Biassoni M, Brofferio C, Bucci C, Caminata A, Canonica L, Cao XG, Capelli S, Cappelli L, Carbone L, Cardani L, Casali N, Cassina L, Chiesa D, Chott N, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick RJ, Cushman JS, Dafinei I, Dally A, Dell'Oro S, Deninno MM, Di Domizio S, Di Vacri ML, Drobizhev A, Ejzak L, Fang DQ, Faverzani M, Fernandes G, Ferri E, Ferroni F, Fiorini E, Freedman SJ, Fujikawa BK, Giachero A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Haller EE, Han K, Hansen E, Heeger KM, Hennings-Yeomans R, Hickerson KP, Huang HZ, Kadel R, Keppel G, Kolomensky YG, Lim KE, Liu X, Ma YG, Maino M, Martinez M, Maruyama RH, Mei Y, Moggi N, Morganti S, Nisi S, Nones C, Norman EB, Nucciotti A, O'Donnell T, Orio F, Orlandi D, Ouellet JL, Pagliarone CE, Pallavicini M, Palmieri V, Pattavina L, Pavan M, Pedretti M, Pessina G, Pettinacci V, Piperno G, Pirro S, Pozzi S, Previtali E, Rosenfeld C, Rusconi C, Sala E, Sangiorgio S, Santone D, Scielzo ND, Sisti M, Smith AR, Taffarello L, Tenconi M, Terranova F, Tomei C, Trentalange S, Ventura G, Vignati M, Wagaarachchi SL, Wang BS, Wang HW, Wielgus L, Wilson J, Winslow LA, Wise T, Zanotti L, Zarra C, Zhang GQ, Zhu BX, Zucchelli S; CUORE Collaboration.

Phys Rev Lett. 2015 Sep 4;115(10):102502. Epub 2015 Sep 3.

37.

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Ravelli A, Reuben JM, Lanza F, Anfossi S, Cappelletti MR, Zanotti L, Gobbi A, Senti C, Brambilla P, Milani M, Spada D, Pedrazzoli P, Martino M, Bottini A, Generali D; Solid Tumor Working Party of European Blood and Marrow Transplantation Society (EBMT).

Tumour Biol. 2015 Sep;36(9):6653-65. doi: 10.1007/s13277-015-3944-7. Epub 2015 Aug 26. Review.

PMID:
26307395
38.

Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response.

Generali D, Berruti A, Cappelletti MR, Zanotti L, Brugnoli G, Forti M, Bedussi F, Vailati ME, Milani M, Strina C, Ardine M, Aguggini S, Allevi G, Ferrero G, Bertoni R, Bottini A, Harris AL, Fox SB.

J Natl Cancer Inst Monogr. 2015 May;2015(51):64-6. doi: 10.1093/jncimonographs/lgv018.

PMID:
26063890
39.

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

Generali D, Ardine M, Strina C, Milani M, Cappelletti MR, Zanotti L, Forti M, Bedussi F, Martinotti M, Amoroso V, Sigala S, Simoncini E, Berruti A, Bottini A.

J Natl Cancer Inst Monogr. 2015 May;2015(51):32-5. doi: 10.1093/jncimonographs/lgv019.

PMID:
26063883
40.

Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.

Ravelli A, Reuben JM, Lanza F, Anfossi S, Cappelletti MR, Zanotti L, Gobbi A, Milani M, Spada D, Pedrazzoli P, Martino M, Bottini A, Generali D; Solid Tumor Working Party of the European Blood and Marrow Transplantation Society (EBMT).

Expert Rev Anticancer Ther. 2015 Jun;15(6):689-702. doi: 10.1586/14737140.2015.1042864. Epub 2015 Apr 30. Review.

PMID:
25927868
41.

Psychological aspects of hyperandrogenic states in late adolescent and young women.

Guidi J, Gambineri A, Zanotti L, Fanelli F, Fava GA, Pasquali R.

Clin Endocrinol (Oxf). 2015 Dec;83(6):872-8. doi: 10.1111/cen.12783. Epub 2015 May 6.

PMID:
25823959
42.

Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.

Sala E, Genua M, Petti L, Anselmo A, Arena V, Cibella J, Zanotti L, D'Alessio S, Scaldaferri F, Luca G, Arato I, Calafiore R, Sgambato A, Rutella S, Locati M, Danese S, Vetrano S.

Gastroenterology. 2015 Jul;149(1):163-176.e20. doi: 10.1053/j.gastro.2015.03.013. Epub 2015 Mar 17.

PMID:
25790743
43.

Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues.

Romani C, Calza S, Todeschini P, Tassi RA, Zanotti L, Bandiera E, Sartori E, Pecorelli S, Ravaggi A, Santin AD, Bignotti E.

PLoS One. 2014 Dec 4;9(12):e113781. doi: 10.1371/journal.pone.0113781. eCollection 2014.

44.

Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.

Sereni MI, Baldelli E, Gambara G, Deng J, Zanotti L, Bandiera E, Bignotti E, Ragnoli M, Tognon G, Ravaggi A, Meani F, Memo M, Angioli R, Liotta LA, Pecorelli SL, Petricoin E 3rd, Pierobon M.

Proteomics. 2015 Jan;15(2-3):365-73. doi: 10.1002/pmic.201400214.

PMID:
25311472
45.

Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.

Zanotti L, Bottini A, Rossi C, Generali D, Cappelletti MR.

Tumour Biol. 2014 Sep;35(9):8461-70. doi: 10.1007/s13277-014-2366-2. Epub 2014 Jul 23. Review.

PMID:
25048969
46.

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy.

Koukourakis MI, Giatromanolaki A, Bottini A, Cappelletti MR, Zanotti L, Allevi G, Strina C, Ardine M, Milani M, Brugnoli G, Martinotti M, Ferrero G, Bertoni R, Ferrozzi F, Harris AL, Generali D.

Br J Cancer. 2014 Apr 29;110(9):2209-16. doi: 10.1038/bjc.2014.196. Epub 2014 Apr 10.

47.

Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.

Bandiera E, Zanotti L, Fabricio AS, Bucca E, Squarcina E, Romani C, Tassi R, Bignotti E, Todeschini P, Tognon G, Romagnolo C, Gion M, Sartori E, Maggino T, Pecorelli S, Ravaggi A.

Clin Chem Lab Med. 2013 Sep;51(9):1815-24. doi: 10.1515/cclm-2013-0151.

PMID:
24013103
48.

Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.

Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A, Pasquali R.

J Clin Endocrinol Metab. 2013 Oct;98(10):E1575-82. doi: 10.1210/jc.2013-1107. Epub 2013 Aug 8.

PMID:
23928669
49.

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.

Bignotti E, Tassi RA, Calza S, Ravaggi A, Rossi E, Donzelli C, Todeschini P, Romani C, Bandiera E, Zanotti L, Carnazza M, Quadraro F, Tognon G, Sartori E, Pecorelli S, Roque DM, Santin AD.

J Transl Med. 2013 Jul 2;11:162. doi: 10.1186/1479-5876-11-162.

50.

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Bellone S, Tassi R, Betti M, English D, Cocco E, Gasparrini S, Bortolomai I, Black JD, Todeschini P, Romani C, Ravaggi A, Bignotti E, Bandiera E, Zanotti L, Pecorelli S, Ardighieri L, Falchetti M, Donzelli C, Siegel ER, Azodi M, Silasi DA, Ratner E, Schwartz PE, Rutherford TJ, Santin AD.

Br J Cancer. 2013 Jul 23;109(2):462-71. doi: 10.1038/bjc.2013.315. Epub 2013 Jun 27.

Supplemental Content

Loading ...
Support Center